Quest Diagnostics Inc
DUS:QDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Diagnostics Inc
DUS:QDI
|
US |
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
S
|
Sunindo Pratama PT Tbk
IDX:SUNI
|
ID |
|
Healthcare Integrated Technologies Inc
OTC:HITC
|
US |
|
Cognizant Technology Solutions Corp
NASDAQ:CTSH
|
US |
|
Vodafone Group PLC
LSE:VOD
|
UK |
|
A
|
ADVFN PLC
OTC:AVFCF
|
UK |
|
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
US |
|
Clickstream Corp
OTC:CLIS
|
US |
|
Keurig Dr Pepper Inc
NASDAQ:KDP
|
US |
|
V
|
Venus Concept Inc
F:0RR1
|
CA |
Wall St Price Targets
QDI Price Targets Summary
Quest Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for QDI is 188.6 EUR with a low forecast of 150.84 EUR and a high forecast of 214.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QDI's stock price target?
Price Target
188.6
EUR
According to Wall Street analysts, the average 1-year price target for QDI is 188.6 EUR with a low forecast of 150.84 EUR and a high forecast of 214.36 EUR.
What is the Revenue forecast for Quest Diagnostics Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 4%.
What is the Operating Income forecast for Quest Diagnostics Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Quest Diagnostics Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 6 years is 10%.
